Umerox Device

Umerox Device – a device for inhalation use of the drug Umerox, vapors for inhalation (methoxyflurane).

Umerox vapors (low-dose methoxyflurane) provide analgesia.

According to the ATС classification, Umerox is an analgesic (N02BG09).

Main indications:

• For emergency relief of pain by self administration in conscious haemodynamically stable patients with trauma and associated pain under the supervision of personnel trained in the use of this medicinal product.
• For the relief of pain in conscious patients who are under observation and require analgesia during surgical procedures such as dressing changes.

Inhalation analgesic Umerox (methoxyflurane) provides:

• rapid onset of analgesic action (1);
• reducing the level of anxiety (2);
• painless, atraumatic administration – without injections, without needles;
• the patient is conscious and controls the degree of anesthesia (3);
• non-opioid (1);
• does not require control of respiratory and cardiovascular system during use (4).

The Umerox Device:

• light and portable – weight 2.3 kg
• simple and easy to use:
  • tracking the amount of medicine in the vial

  • updating information on the received dose of medication after each inhalation

  • suitable for use in both hospital and outpatient settings

Before the procedure, a separate procedure kit should be prepared for each patient, which includes a nasal clip and an individual mouthpiece with a filtering membrane.

Nasal clip

The mouthpiece is individual with a filter membrane

Do not use the Umerox Device if the mouthpiece cannot be used or if the patient’s condition does not allow it to be used according to the instructions.

More details about Umerox in the video:

Umerox Device can be used only as prescribed by a doctor and under the supervision of medical personnel in the conditions of health care institutions. The dosage and mode of use of the medicinal product are determined by the doctor in accordance with the instructions for the use of the medicinal product.

Sources of information:

1. Keith M Porter, Anthony D Dayan, Sara Dickerson, Paul M Middleton, Published 18 October 2018 Volume 2018:10 Pages 149—164. The role of inhaled methoxyflurane in acute pain management, doi.org/10.2147/OAEM.S181222.

2. Br J Anaesth. 2018 May; 120(5):1040-1048. doi: 10.1016/j.bja.2018.01.011.

3. Дубров Сергій Олександрович, Черняєв Степан Володимирович, Метоксифлуран: історичний огляд та аналіз безпеки використання як анальгетика при невідкладних та амбулаторних процедурах. Журнал “Pain, Anaesthesia & Intensive Care”, № 3, 2024.

4. Porter KM, Dayan AD, Dickerson S, Middleton PM. The role of inhaled methoxyflurane in acute pain management. Open Access Emergency Medicine [Internet]. 2018 Oct; Volume 10:149–64. Available from: dx.doi.org/10.2147/oaem.s181222.